About On Target Laboratories
On Target Laboratories is a company based in West Lafayette (United States) founded in 2010 by Phil S Low. On Target Laboratories has raised $116.5 million across 8 funding rounds from investors including Olympus, HHS and H.I.G. Capital. The company has 29 employees as of December 31, 2023. On Target Laboratories offers products and services including CYTALUX. On Target Laboratories operates in a competitive market with competitors including Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics, Averto Medical, Guerbet and C-RAD, among others.
- Headquarter West Lafayette, United States
- Employees 29 as on 31 Dec, 2023
- Founders Phil S Low
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name On Target Laboratories, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$116.5 M (USD)
in 8 rounds
-
Latest Funding Round
$30 M (USD), Series C
Nov 16, 2023
-
Investors
Olympus
& 12 more
-
Employee Count
29
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of On Target Laboratories
On Target Laboratories offers a comprehensive portfolio of products and services, including CYTALUX.
FDA-approved agent for detecting and illuminating tumors during cancer surgery.
People of On Target Laboratories
Unlock access to complete
Funding Insights of On Target Laboratories
On Target Laboratories has successfully raised a total of $116.5M across 8 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in On Target Laboratories
On Target Laboratories has secured backing from 13 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Olympus, HHS and H.I.G. Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage healthcare investments are made by 3B Future Health Fund.
|
Locked | Locked | Locked | |
|
Early-stage investments are made in diverse sectors by the firm.
|
Locked | Locked | Locked | |
|
Venture capital firm backed by Johnson & Johnson
|
Locked | Locked | Locked |
Investor details for On Target Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by On Target Laboratories
Investment portfolio details for On Target Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - On Target Laboratories
Detailed financials for On Target Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
On Target Laboratories Comparisons
Peer comparison for On Target Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of On Target Laboratories
On Target Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics, Averto Medical, Guerbet and C-RAD, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| Locked | Locked | Locked |
Developer of fluorescence-guided imaging technologies to help surgeons detect residual cancer tissue during operations
|
|
| Locked | Locked | Locked |
Medical devices for gastrointestinal disease patients are developed.
|
|
| Locked | Locked | Locked |
Contrast agents and delivery systems are developed for medical imaging.
|
|
| Locked | Locked | Locked |
Oncology treatments are delivered through standalone clinics.
|
Detailed competitors of On Target Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on On Target Laboratories
Complete news archive for On Target Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about On Target Laboratories
On Target Laboratories was founded in 2010 and raised its 1st funding round 4 years after it was founded.
On Target Laboratories is headquartered in West Lafayette, United States. It is registered at West Lafayette, Indiana, United States.
Chris Barys is the current CEO of On Target Laboratories.
On Target Laboratories is a funded company, having raised a total of $116.5M across 8 funding rounds to date.
As of Dec 31, 2023, the latest employee count at On Target Laboratories is 29.
On Target Laboratories was founded in 2010 in West Lafayette, United States. Focus is placed on the biotechnology sector, where molecular imaging agents are developed to assist in cancer surgery. Fluorescent markers based on this technology are supplied to highlight cancerous tissue during procedures, allowing for targeted removal. Key roles are held by Phil S. Low as Founder and Chief Science Officer, and Chris Barys as CEO and President.
On Target Laboratories's top competitors include Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics and Guerbet.
On Target Laboratories offers CYTALUX.
On Target Laboratories has 13 investors. Key investors include Olympus, HHS, H.I.G. Capital, Johnson & Johnson Innovation, and Pension Fund.